Total knee arthroplasty in dialysis patients: a national in-patient sample-based study of perioperative complications.

Chronic kidney disease Cost of care Dialysis Length of stay Postoperative complications Total knee arthroplasty

Journal

Knee surgery & related research
ISSN: 2234-0726
Titre abrégé: Knee Surg Relat Res
Pays: England
ID NLM: 101575761

Informations de publication

Date de publication:
02 Aug 2023
Historique:
received: 19 12 2022
accepted: 18 07 2023
medline: 3 8 2023
pubmed: 3 8 2023
entrez: 2 8 2023
Statut: epublish

Résumé

Chronic kidney disease (CKD) is a growing disease that affects millions of people in the USA every year. Many CKD patients progress to end-stage renal disease (ESRD), necessitating the use of hemodialysis to alleviate symptoms and manage kidney function. Furthermore, many of these patients have lower bone quality and experience more postoperative complications. However, there is currently limited information on hospitalization information and perioperative complications in this population following procedures such as total knee arthroplasty (TKA). The purpose of this study was to assess the patient characteristics, demographics, and prevalence of postoperative problems among dialysis patients who received TKA. In this retrospective study, we used the Nationwide Inpatient Sample (NIS) data from 2016 to 2019 to analyze the incidence of perioperative complications, length of stay (LOS), and the cost of care (COC) among patients undergoing TKA who were categorized as dialysis patients, compared with those who were not. Propensity matching was conducted to consider associated factors that may influence perioperative complications. From 2016 to 2019, 558,371 patients underwent TKAs, according to the National In-Sample (NIS) database. Of those, 418 patients (0.1%) were in the dialysis group, while the remaining 557,953 patients were included in the control group. The mean age of the dialysis group was 65.4 ± 9.8 years, and the mean age in the control group was 66.7 ± 9.5 years (p = 0.006). After propensity matching, dialysis group patients had a higher risk of receiving blood transfusions [odds ratio (OR): 2; 95% confidence interval (CI): 1.2, 3.4] and a significantly larger COC in comparison to those in the control group (91,434.3 USD versus 71,943.6 USD, p < 0.001). In addition, dialysis patients had significantly higher discharges to another facility, as compared with the control group patients. The dialysis group had a significantly higher cost of care, higher rates of requiring blood transfusion, and more cases of being discharged to another facility than non-dialysis patients. This data will help providers make informed decisions about patient care and resource allocation for dialysis patients undergoing TKA.

Sections du résumé

BACKGROUND BACKGROUND
Chronic kidney disease (CKD) is a growing disease that affects millions of people in the USA every year. Many CKD patients progress to end-stage renal disease (ESRD), necessitating the use of hemodialysis to alleviate symptoms and manage kidney function. Furthermore, many of these patients have lower bone quality and experience more postoperative complications. However, there is currently limited information on hospitalization information and perioperative complications in this population following procedures such as total knee arthroplasty (TKA). The purpose of this study was to assess the patient characteristics, demographics, and prevalence of postoperative problems among dialysis patients who received TKA.
METHODS METHODS
In this retrospective study, we used the Nationwide Inpatient Sample (NIS) data from 2016 to 2019 to analyze the incidence of perioperative complications, length of stay (LOS), and the cost of care (COC) among patients undergoing TKA who were categorized as dialysis patients, compared with those who were not. Propensity matching was conducted to consider associated factors that may influence perioperative complications.
RESULTS RESULTS
From 2016 to 2019, 558,371 patients underwent TKAs, according to the National In-Sample (NIS) database. Of those, 418 patients (0.1%) were in the dialysis group, while the remaining 557,953 patients were included in the control group. The mean age of the dialysis group was 65.4 ± 9.8 years, and the mean age in the control group was 66.7 ± 9.5 years (p = 0.006). After propensity matching, dialysis group patients had a higher risk of receiving blood transfusions [odds ratio (OR): 2; 95% confidence interval (CI): 1.2, 3.4] and a significantly larger COC in comparison to those in the control group (91,434.3 USD versus 71,943.6 USD, p < 0.001). In addition, dialysis patients had significantly higher discharges to another facility, as compared with the control group patients.
CONCLUSIONS CONCLUSIONS
The dialysis group had a significantly higher cost of care, higher rates of requiring blood transfusion, and more cases of being discharged to another facility than non-dialysis patients. This data will help providers make informed decisions about patient care and resource allocation for dialysis patients undergoing TKA.

Identifiants

pubmed: 37533126
doi: 10.1186/s43019-023-00196-0
pii: 10.1186/s43019-023-00196-0
pmc: PMC10394770
doi:

Types de publication

Journal Article

Langues

eng

Pagination

22

Informations de copyright

© 2023. The Author(s).

Références

J Am Soc Nephrol. 2020 Mar;31(3):456-468
pubmed: 32041774
J Arthroplasty. 2018 Jul;33(7):2263-2267
pubmed: 29551305
Am J Kidney Dis. 2017 Mar;69(3 Suppl 1):A7-A8
pubmed: 28236831
BMC Musculoskelet Disord. 2021 Nov 3;22(1):927
pubmed: 34732184
J Rheumatol. 2019 Sep;46(9):1134-1140
pubmed: 30988126
J Am Acad Orthop Surg Glob Res Rev. 2019 Aug 06;3(8):e086
pubmed: 31592508
J Am Soc Nephrol. 2021 Jul;32(7):1551-1558
pubmed: 34140394
J Bone Joint Surg Am. 2015 Aug 19;97(16):1326-32
pubmed: 26290083
J Arthroplasty. 2018 Mar;33(3):872-877
pubmed: 29107488
Biomed J. 2021 Oct;44(5):620-626
pubmed: 32389822
Perit Dial Int. 2015 Nov;35(6):659-62
pubmed: 26702009
J Am Soc Nephrol. 2016 Sep;27(9):2825-32
pubmed: 26823554
J Am Soc Nephrol. 2021 Jul;32(7):1583-1598
pubmed: 33941607
Clin Orthop Relat Res. 2013 Jan;471(1):201-5
pubmed: 22528384
J Orthop. 2021 May 14;25:199-206
pubmed: 34045823
Indian J Endocrinol Metab. 2012 Mar;16 Suppl 1:S27-36
pubmed: 22701840

Auteurs

Nikit Venishetty (N)

Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USA. nikit.venishetty@ttuhsc.edu.

Dane K Wukich (DK)

Department of Orthopedics, University of Texas Southwestern, Dallas VAMC, Dallas, TX, USA.

Jack Beale (J)

Department of Orthopedics, University of Texas Southwestern, Dallas VAMC, Dallas, TX, USA.

J Riley Martinez (J)

Department of Orthopedics, University of Texas Southwestern, Dallas VAMC, Dallas, TX, USA.

Michel Toutoungy (M)

Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USA.

Varatharaj Mounasamy (V)

Department of Orthopedics, University of Texas Southwestern, Dallas VAMC, Dallas, TX, USA.

Senthil Sambandam (S)

Department of Orthopedics, University of Texas Southwestern, Dallas VAMC, Dallas, TX, USA.

Classifications MeSH